Article
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
CEO Albert Bourla Kicks Off Pfizer’s 175th Anniversary Celebration
For 175 years, Pfizer has been at the forefront of medical and pharmaceutical breakthroughs that have not only changed patient lives but have impacted the world. From the advent of penicillin to the development of the COVID-19 vaccine, we have harnessed the brilliance, expertise, and innovation of countless scientists, doctors, and researchers to help shepherd the world through some of its most difficult healthcare challenges.This year, we celebrate those breakthroughs as we mark the company’s...
December Social Media Round-Up—Welcome Seagen, US/India CEO Forum, AI, and Gratitude
DECEMBER SOCIAL MEDIA ROUND-UPThe last month of the year tends to be rather hectic, as the holidays descend and everyone scrambles to wrap things up before spending time with their families, friends, and loved ones. Here at Pfizer, December was just as action-packed as the rest of the year. In our monthly round-up of our leadership’s social media activity, Pfizer’s CEO speaks about the acquisition of Seagen, the Nobel Prize committee honors a pair of scientists integral to development of the...
The Stars Come Out for Pfizer-Sponsored “Divas Simply Singing!” Benefit Concert
Health and science aren’t always the most glamorous work, but sometimes we get to rub shoulders with celebrities when the stars come out in support of important health issues.That’s what happened earlier this month, when Pfizer’s Vaccine Adoption and Equity team sponsored the 33rd Sheryl Lee Ralph & the DIVA Foundation Presents: DIVAS Simply Singing! benefit concert.For over three decades, Sheryl Lee Ralph, Emmy Award Winning star of the hit ABC show, Abbot Elementary, has hosted the DIVAS...
Pfizer Accelerates Climate Action through Pan-European Virtual Power Purchase Power Agreements
The impact of climate change on human health is unequivocal. Between 2030 and 2050, it’s expected to cause 250,000 additional deaths per year1 from increased effects like heat stress and malnutrition.Guided by our company purpose, “Breakthroughs that change patients’ lives”, Pfizer remains committed to reducing our company’s greenhouse gas (GHG) emissions. We’ve set a goal to achieve to achieve the voluntary Net-Zero Standard – aiming to reduce company emissions by 95% and value chain emissions...
Pfizer Launches VaxAssist, to Help Individual’s Assess Respiratory Vaccine Eligibility
As more respiratory vaccinations have become available in recent years, the Centers for Disease Control and Prevention (CDC) continues to provide annual guidelines for common respiratory illnesses—COVID-19, pneumococcal pneumonia, influenza (the flu), and respiratory syncytial virus (RSV)—to help ensure eligible populations are seeking vaccinations, especially during respiratory illness season.1,2,3,4,5,6 Pfizer has launched VaxAssist, an online tool that helps adults 18 and older check their...
ASH 2023: Advancing Potential Breakthroughs for Patients with Hematologic Disorders
This weekend, Pfizer will be joining the hematology/oncology community at the 65th Annual Meeting of the American Society of Hematology (ASH), the premier professional society of clinicians and scientists dedicated to conquering blood diseases.Blood diseases can disrupt a broad range of essential functioning – from providing the body with oxygen and nutrients, to fighting the growth of cancer, to preventing excessive bleeding. Pfizer is advancing novel approaches to blood diseases with next...
November Social Media Round-Up—Vaccine Anniversary, Transgender Awareness, and the Corporate Equality Index
Thanksgiving may have kicked off the holiday season, but November was chock full of things to celebrate all month long, including Transgender Awareness Week and Veterans Day. On social media, Pfizer’s leadership reflected on those occasions, and our CEO considered the cure for the epidemic of exclusion and celebrated the three-year anniversary of the moonshot heard around the world.Get caught up below with November’s social media round-up!From Our LeadershipCEO Albert Bourla reflects on the...
Pfizer’s 2-in 1 At-Home Test Enables Convenient Testing for both COVID-19 and the Flu
When we think of winter, hot chocolate, cozy fireplaces, and catching up with friends and family often come to mind. But 'tis also peak respiratory virus season1, with viruses like the flu and COVID-19 making the rounds at holiday parties and gatherings everywhere. To further complicate matters, symptoms of COVID-19 and the flu present very similarly: fever, cough, runny nose, sore throat, and body aches2. These similarities in symptoms can make it difficult for people to differentiate between...
Listen Now: Award-Winning ‘Science Will Win’ Podcast Explores Antimicrobial Resistance
This week, season three of Pfizer’s signature Science Will Win podcast—which debuted as one of the top 1% podcasts globally—returns with a look at antimicrobial resistance (AMR), one of healthcare’s greatest threats, and the innovative ways doctors and scientists are leveraging emerging technology to fight it.The ambitious new season follows last year’s award-winning foray into the latest advancements in cancer treatment. In last season’s episodes, host Adam Rutherford and a variety of guests...
Pfizer CEO Albert Bourla Discusses Curing the Epidemic of Exclusion at APEC CEO Summit
This week, the annual APEC CEO Summit was held in San Francisco, California. The Summit brought CEOs, entrepreneurs, thought leaders and other stakeholders together with senior political leaders from the Asia-Pacific region for two days of dialogue. This year’s Summit focused on “Creating Economic Opportunity” via sustainability, inclusion, resilience, and innovation.On Thursday, Pfizer CEO Albert Bourla delivered one of the Summit CEO Spotlight speeches, with remarks focused on “Curing the...
The Importance of Returning Clinical Trial Data to Participants
Clinical trial participants are at the heart of medical research, and it’s with their help that Pfizer is able to bring life-changing treatments to patients.But, until recently, clinical trial sponsors like Pfizer have not been equipped to provide participants with their own personal clinical trial data when a trial ends. Pfizer’s team of clinical trial experts have worked for many years to change that by launching the Clinical Trial Participant Data Return Initiative.This first-of-its-kind...
October Social Media Round-Up—Israel-Hamas War, COVID-19 Treatment News, and Pfizer Makes Forbes List
October was an eventful month, both around the world and here at Pfizer. In this edition of the monthly social media round-up, our leadership weighs in on both. CEO Albert Bourla expresses sadness and resolve over the geopolitical upheaval in the middle east, which has far-reaching implications, including impact on many employees in the Pfizer family. He also spreads the news about our new deal with the U.S. government regarding the COVID-19 antiviral oral treatment. And our Chief Marketing...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.